Crinecerfont
NBI-74788-CAH2008
Phase 2 small_molecule completed
Quick answer
Crinecerfont for CAH - Congenital Adrenal Hyperplasia is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- CAH - Congenital Adrenal Hyperplasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed